FP-loaded SLN formulations were manufactured using a high pressure homogenizer. Tristearin was melted and 50 mg of FP was added to the melted lipid. Aqueous Tween 80 (1%) solution was also heated to the same temperature. After an Ultraturrax T25 (IKA, Germany) at 13.500 rpm was used to mix the lipid phase and aqueous phase for 3 min, the hot pre-emulsion was subsequently homogenized by a Microfluidics M110L (USA) at a pressure of 18.000 Psi. Three different tristearin percentages (1%, 2%, and 4%) and three different cycle numbers (2, 4, and 8 cycles) were investigated based on two responses: encapsulation efficiency (Q1) and particle size (Q2). SLN dispersions were centrifuged using a Vivaspin (MWCO=10.000) at 4500 rpm for 30 min (Sigma 3K30, Germany) and then lyophilized.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.